Public Relations Committee Media forums
We hold lectures for members of the media on topics that are core to our policy advocacy and that meet the needs of the media from time to time.
-
As of December 2023(Affiliations and positions are those at the time of the seminar)
-
Media forums
Two Major Issues in Countermeasures against Infectious Diseases: Countermeasures against Drug-Resistant Bacteria and Proper Understanding of Immunization Part 2
Takeshi Naruse, President, Japan Vaccine Industry Association, Inc.
Mr. Akihisa Maeda, Director, Immunization Division, Department of Infectious Disease Control, Health and Welfare Bureau, Ministry of Health, Labour and Welfare
Dr. Motoi Suzuki, Director, Center for Epidemiology of Infectious Diseases, National Institute of Infectious Diseases, National Institute of Health Risk Management -
Media forums
Two Major Issues in Countermeasures against Infectious Diseases: Countermeasures against Drug-Resistant Strains of Bacteria and Proper Understanding of Immunization Part I
Dr. Manabu Sumi, Director, Infectious Disease Control Division, Health and Welfare Bureau, Ministry of Health, Labour and Welfare
Dr. Hiroshi Yotsuyanagi, Director, National Institute of Health Risk Management
Kazuhiko Mori, Executive Director, Japan Pharmaceutical Manufacturers Association -
Media forums
Diverse Values of Drugs "What are the diverse values brought by new modalities - a case study of spinal muscular atrophy (SMA)?
Dr. Reiko Arakawa, Medical Director, Department of Clinical Genomics, National Center for Global Health and Medicine
Ms. Yuko Oyama, Chairman, Spinal Muscular Atrophy (SMA) Family Association
Dr. Tsutomu Goto, Professor, Graduate School of Business Administration, Keio University -
Media forums
Efforts to deal with priority infectious diseases (including AMR) - Introduction of the revised Government Action Plan for H1N1 Influenza and future measures - (2) Promotion of countermeasures against AMR
Dr. Eiji Kusaka, Deputy Director-General, Cabinet Office, Cabinet Office, Government of Japan
Dr. Takao Omagari, Director, Center for Global Infectious Diseases, National Center for Global Health and Medicine / Director, AMR Clinical Reference Center, National Center for Global Health and Medicine
Nobuo Murakami, Chairman, International Committee, Japan Pharmaceutical Manufacturers Association (JPMA) -
Media forums
Life Course Immunization in the 100-year life era
Toru Tanzawa, Chair, Vaccine Working Committee, Biopharmaceutical Committee, Pharmaceutical Manufacturers Association of Japan
Akihiko Saito, Professor, Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences -
Media forums
Considering the Diverse Values of Pharmaceuticals - For the Rich Daily Lives Desired by Patients and Their Families
Dr. Kanako Kikuchi, Chief, Department of Dermatology, Mitsui Memorial Hospital
Nahoko Shirado, Associate Professor, Department of Obstetrics and Gynecology, Showa University School of Medicine
Tadashi Kato, Professor, Department of Psychiatry, Juntendo University School of Medicine -
Media forums
Action Plan 2023-2027 to combat drug resistance (AMR) - Key points and future actions
Dr. Tomohiro Onishi, Deputy Director-General, Office of Countermeasures to Combat Infectious Diseases, Cabinet Secretariat
Hiroshi Yotsuyanagi, Professor, Research Center for Advanced Medical Science, Institute of Medical Science, University of Tokyo
Yusuke Ariyoshi, Leader, Infectious Disease Group, International Committee, Pharmaceutical Manufacturers Association of Japan -
Media forums
Health and Economy: "The World's Attention: The Future of Health Economics Research in Japan's Aging Society" (Japanese only)
Associate Professor, Graduate School of Economics, Hitotsubashi University -
Media forums
What to do about vaccines? -What we can do now for the future
Dr. Daisuke Inoue, Assistant Director, Office of the Counselor for Immunization, Health Bureau, Ministry of Health, Labour and Welfare
Dr. Satoshi Haranami, Executive Director, Japan Medical Association -
Media forums
Trends in Science, Technology, and Innovation from an Overhead View of the Life Science Field and Implications for the Drug Discovery Field
Dr. Hiroki Shimazu, Life Science and Clinical Medicine Unit, Center for Research and Development Strategy, Japan Science and Technology Agency -
Media forums
Drug Resistance (AMR) Promotion Month
Ms. Akiko Honda, Parliamentary Secretary, Minister of Health, Labour and Welfare, Member of the House of Councillors
Mr. Tomohiro Onishi, Deputy Director-General, Cabinet Secretariat, Office of Countermeasures to Combat Infectious Diseases including the New Type IV Coronavirus
Kazuhiro Tateda, Professor, Toho University / Chairman, Joint Committee of Seven Academic Societies for the Promotion of Therapy and Drug Discovery for Infectious Diseases
Dr. Yui Kono, Manager, Japan Health Policy Organization (JHPO)
Yusuke Ariyoshi, Leader, Infectious Disease Group, Global Health Subcommittee, International Committee, Pharmaceutical Manufacturers Association of Japan -
Media forums
Aiming for Appropriate Use of Drugs - To deliver reliable drug information to patients
Ms. Tomiko Tawaraki, President, Japan Association for the Appropriate Use of Drugs -
Media forums
Considering the Diverse Values of Pharmaceuticals - For the Rich Daily Lives Desired by Patients and Their Families
Associate Professor, Yokohama City University School of Medicine, Health and Social Medicine Unit / Visiting Associate Professor, Department of Pharmaceutical Policy, Graduate School of Pharmaceutical Sciences, The University of Tokyo
Eiichi Tanaka, Associate Professor, Department of Internal Medicine, Tokyo Women's Medical University
Dr. Koichi Hirata, Vice President, Dokkyo Medical University -
Media forums
Current status of drug resistance (AMR) and the need for new antimicrobial agents to address this issue
Dr. Takao Omagari, International Center for Infectious Diseases, National Center for Global Health and Medicine, Japan
Department of Infectious Diseases, National Cancer Center Hospital East, and Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Central Hospital (concurrent appointment)
International Committee, Pharmaceutical Manufacturers Association of Japan (PALMA)
Akira Yuasa, Member, International Committee, Japan Pharmaceutical Manufacturers Association (JPMA) -
Media forums
Vaccination in the Era of With Corona ~Learning from Pandemics
Takashi Nakano, Professor, Department of Pediatrics, Kawasaki Medical School -
Media forums
The need for new antimicrobial agents against drug resistance (AMR) reaffirmed by the new coronavirus pandemic
Tetsuya Matsumoto, Professor, International University of Health and Welfare, School of Medicine
Kazuhiro Tateda, Professor, Toho University School of Medicine
Dr. Michito Shibata, Manager, Japan Health Policy Organization (JHPO) -
Media forums
Reconsidering the Diverse Values of Pharmaceuticals - What Contributions to Society are Expected from Pharmaceuticals?
Professor, Health Policy and Technology Assessment Research Project, Graduate School of Public Policy, The University of Tokyo / Senior Director of Health Policy Research, Canon Institute for Global Studies / President-Elect, International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Japan
Associate Professor, Health and Social Medicine Unit, Yokohama City University School of Medicine / Visiting Associate Professor, Graduate School of Pharmaceutical Sciences, University of Tokyo Dr. Naka Igarashi -
Media forums
What is a vaccine? -In the wake of the Corona Disaster, we need to learn about vaccines once again.
Nobuhiko Okabe, Director, Kawasaki Institute for Health and Safety Research -
Media forums
Trends in the revision of the Personal Information Protection Law and the legislative policy for medical information
Professor, Graduate School of Modern Society and Culture, Faculty of Law, Niigata University -
Media forums
Lifetime Immunization
Kazunori Oishi, Director, Center for Infectious Disease Epidemiology, National Institute of Infectious Diseases -
Media forums
The value revolution in healthcare at the Pharmaceutical Cooperative Association of Japan
Professor, Department of Health Care Policy and Management, Faculty of Medicine, Keio University -
Media forums
Concept of Vaccine Efficacy and Safety -From an Epidemiological Perspective
Professor, Department of Public Health, Osaka City University Graduate School of Medicine -
Media forums
Efforts in Japan Against Drug Resistance (AMR)
Dr. Toru Kajiwara, Director, Office of International Health and Cooperation, Ministry of Health, Labour and Welfare
Professor, Department of Microbiology and Infectious Diseases, Faculty of Medicine, Toho University
Eiichi Yamaguchi, Secretary, International Committee, Pharmaceutical Manufacturers Association of Japan -
Media forums
Application of AI/Big Data in the Medical Health Field
Dr. Masami Morita, Senior Researcher, Pharmaceutical and Industrial Policy Research Institute (PIIPRI)
Dr. Yasushi Okuno, Professor, Department of Big Data Medical Science, Division of Human Health Science, Graduate School of Medicine, Kyoto University -
Media forums
Infectious Disease Control as Crisis Management
Dr. Satoshi Iwata, Department of Infectious Diseases, National Cancer Center Hospital -
Media forums
AMED and Orphan Drug Development - Toward Practical Application
Dr. Akiko Hayashi, Research Officer, East Japan Strategic Planning Group, Drug Discovery Support Strategy Department, Japan Agency for Medical Research and Development -
Media forums
Exploring Japan's Contribution in Global Health
Dr. Tomohiko Sugishita, International Cooperation Specialist, Japan International Cooperation Agency (JICA)
Ms. Sayoko Sasaki, Vice-Chair, Global Health Subcommittee, International Committee, Japan Pharmaceutical Manufacturers Association (JPMA) -
Media forums
The Latest Cancer Treatment -Cancer Immunotherapy
Dr. Hiroyoshi Nishikawa, Director, Immunology TR, National Cancer Center -
Media forums
How far have we moved? Immunization System and Countermeasures against Infectious Diseases
Dr. Nobuhiko Okabe, Director, Health and Safety Research Institute, Kawasaki City